Clinical Trials List
2011-04-01 - 2018-07-31
Phase III
Terminated4
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Kun-Huei Yeh Division of Hematology & Oncology
- Wen-Fang Cheng Division of Obstetrics & Gynecology
- MING YAO Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 蔡俊明 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Min-Yu Chen Division of Obstetrics & Gynecology
- Chih-Hung Chen Division of Thoracic Medicine
- 黃寬仁 Division of Obstetrics & Gynecology
- Cheng-Ta Yang Division of Thoracic Medicine
- Wen-Cheng Chang Division of Hematology & Oncology
- Cheng-Tao Lin Division of Obstetrics & Gynecology
- Chien-Ying Liu Division of Thoracic Medicine
- Ting-Chang Chang Division of Obstetrics & Gynecology
- Chih-Liang Wang Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Li-Yuan Bai Division of Hematology & Oncology
- Chen-Yuan Lin Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
100 participants
-
Global
5136 participants
